Unlike other investment banks, the fast-growing New York firm offers upfront payment instead of deferred stock. It seems to ...
John Colantuoni, senior internet analyst at Jefferies, joins CNBC's 'The Exchange' to share why Zillow is his top pick.
Investment bank Jefferies Financial Group Inc. has hired former Alnylam Pharmaceuticals Inc. Chief Executive Officer John ...
They need to find a bigger venue,” an attendee mutters as they pull their coat tight and brave the British rain to find one ...
After The Wall Street Journal reported yesterday that QXO (QXO), which is “effectively a SPAC,” has made an offer to acquire Beacon (BECN), ...
The Biden Administration, in September this year, rolled out new export controls on critical technologies, including quantum ...
Jefferies retains a Buy on Indian Hotels with a Rs 785 target, citing robust AHVAAN 2025 progress, 68% YTD stock gain, and ...
Jefferies analyst Akash Tewari maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of ...
today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference, taking place in London, United Kingdom on Tuesday, November 19, 2024 at 10:30 a.m ...
At Sounds Great, the comedy show she co-hosts in Brooklyn, Nora Jefferies and her fellow comedians warm up the crowd with a ...
Jefferies believes the selloff in Intuit (INTU) shares following a Washington Post report of a potential Internal Revenue Service mobile tax ...
Jefferies has an Underperform rating on Palantir and a price target of $28; PLTR shares are changing hands for $62.2 in Tuesday's early market trading. This article first appeared on GuruFocus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback